NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AION Labs

AION Labs

Overview

AION Labs is a venture studio that creates and invests in startups leveraging artificial intelligence and computational science to address challenges in pharmaceutical drug discovery and development. It operates as an alliance of pharmaceutical companies AstraZeneca, Merck, Pfizer, and Teva, venture capital firms Israel Biotech Fund and Amiti Ventures, and technology partner Amazon Web Services (AWS), with support from the Israel Innovation Authority.

Year Founded

2021

Portfolio Companies

5

Investments

AION Labs investments
CompanyDateStageLead
Promise BioDec 2024SeedCo-investor
Cellyrix TherapeuticsDec 2024SeedLead
TenAces BiosciencesJan 2024SeedCo-investor
DenovAI BiotechJan 2024SeedCo-investor
DenovAI BiotechFeb 2023Pre SeedLead

Key People

Christian Tidona

Member of the Board of Directors

Noora Kattouf

Board Observer, Alliance principal

Shiri Netser

Alliance Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersIsrael
Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.